Search

Your search keyword '"Rahmouni, Nesrine"' showing total 441 results

Search Constraints

Start Over You searched for: Author "Rahmouni, Nesrine" Remove constraint Author: "Rahmouni, Nesrine"
441 results on '"Rahmouni, Nesrine"'

Search Results

1. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease

2. In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease

3. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease

4. Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts

5. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

8. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

9. CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

10. APOEε4 potentiates amyloid β effects on longitudinal tau pathology

11. A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases

12. Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

13. Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology

14. 14-3-3 ζ/δ-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2

15. Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

16. Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease

17. In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer's disease.

18. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

19. Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak staging

20. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease.

21. Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females.

23. Sex modulates the role of astrocyte reactivity in preclinical Alzheimer’s disease

24. Synaptic dysfunction, Tau pathology and Neurodegeneration

25. Plasma pTau217: single vs multiple phospho‐site assays.

26. CSF total tau is more closely associated with synaptic dysfunction than overt neurodegeneration

27. Association of reactive astrogliosis and microglial activation with tau pathology in Alzheimer’s disease

28. Increased regional brain inflammation predicts longitudinal brain atrophy in individuals in the Alzheimer’s disease continuum

29. Plasma p‐tau and brain‐derived total tau biomarkers predict longitudinal changes in Aβ, tau, and cognition across the AD continuum

30. Neuroinflammation Exacerbates Irritability and Agitation in Alzheimer’s Disease

31. Mapping the effects of functional and structural network reorganization on the tau‐cognition relationship in Alzheimer’s disease

32. Amyloid β‐dependent tau phosphorylation is triggered by reactive astrocytes in preclinical Alzheimer’s disease

34. Associations and interactions of synaptic and inflammatory biomarkers in Alzheimer's disease

35. Plasma biomarkers as stand‐alone tests in the diagnosis of Alzheimer’s disease

37. Association between glial and synaptic fluid biomarkers and brain [18F]FDG‐PET signal

38. APOEε4 potentiates the effects of Aβ pathology on the deposition of neurofibrillary tangles via tau phosphorylation

39. Interactions of synaptic and inflammatory biomarkers in Alzheimer’s Disease

40. Assessment of brain oxygen extraction in aging and Alzheimer’s disease with MRI images

41. Fast accumulators of tau have higher levels of plasma pTau and stronger associations with amyloid in later Braak regions at baseline

42. Association between brain [18F]FDG‐PET signal and genetic cell markers in the brain tissue

43. The impact of young controls in the detection of tau load in cognitively impaired and asymptomatic elderly

44. Plasma p‐tau 181 outperforms FDG‐PET and plasma‐NfL in the diagnosis of biological AD

45. Plasma p-tau 181 outperforms FDG-PET in the early diagnosis of biological AD

46. Microglial activation interacts with amyloid‐β to drive longitudinal tau tangle accumulation and cognitive decline

47. Astrocyte reactivity is associated with synaptic dysfunction across the aging and Alzheimer’s disease spectrum, whereas microglial reactivity is specifically associated with synaptic dysfunction related to cognitive impairment

48. Potential utility of using both APOEε4 and Aβ positivity to enrich clinical trials of tau‐targeting therapies

49. Sex impacts the association of plasma Glial Fibrillary Acidic Protein with neurodegeneration in Alzheimer’s disease

50. Amyloid‐dependent tau phosphorylation drives faster accumulation of tau aggregates in female

Catalog

Books, media, physical & digital resources